Digestive and breast cancer patients managed during the first wave of COVID-19 pandemic: Short and middle term outcomes

Table 3 Characteristics of colorectal cancer and of the performed surgery

		Colon, n (%)	Rectal, n (%)
Total n (%)		32/28 operated	21 (1 positive)3
Final disease stage	0	1 (3.1)	1 (4.8)
	I	4 (12.5) + 2 (6.2)1	3 (14.3)
	IIA	6 (18.8) + 1 (3.1)1	7 (33.3)
	IIB	6 (18.8)	0
	IIIA	1 (3.1)	4 (19.0)
	IIIB	7 (21.7) + 1 (3.1)2	4 (19.0)
	IIIC	3 (9.4)	0
	IVA	0	2 (9.5)
Resection	R0	28 (100)	18 (90.0)
	R1	0	2 (10.0)
	R2	0	0
CRITCON level	0	13 (46.4)	9 (45.0)
	1	4 (14.3)	4 (20.0)
	2	8 (28.6)	4 (20.0)
	3	3 (10.7)	3 (15.0)
Urgency	Urgent/Expedited	4 (14.3)	0
	Elective	24 (85.7)	20 (100)
Operative approach	Open	10 (35.7)	1 (5.0)
	MIS	15 (53.6)	18 (90)
	MIS-open	3 (10.7)	1 (5.0)
Anastomosis	Yes, with protective stoma	0	5 (25.0)
	Yes	25 (89.3)	3 (15.0)
	No, end stoma only	3 (10.7)	12 (60.0)
Changes in anastomosis practice	No, typical practice	27 (96.4)	18 (90.0)
	Change unrelated to COVID	0	1 (5.0)
	Change due to pandemic	1 (3.6)	1 (5.0)

¹Non operated patient.

²Non operated patient that became operated at August 2020.

³SARS-Cov-2 positive case only considered for staging.

MIS: Minimally invasive surgery; R0: No microscopic disease; R1: Microscopic disease; R2: Macroscopic disease at margin.